Texas § 1575.159 COVERAGE FOR PROSTATE-SPECIFIC ANTIGEN TEST.

Texas Statutes

§ 1575.159 — COVERAGE FOR PROSTATE-SPECIFIC ANTIGEN TEST.

Texas § 1575.159

Code INInsurance Code

This text of Texas § 1575.159 (COVERAGE FOR PROSTATE-SPECIFIC ANTIGEN TEST.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Insurance Code Code Ann. § 1575.159 (2026).

Text

Sec. 1575.159. COVERAGE FOR PROSTATE-SPECIFIC ANTIGEN TEST. A health benefit plan offered under the group program, other than a Medicare Advantage plan or a Medicare prescription drug plan, must provide coverage for a medically accepted prostate-specific antigen test used for the detection of prostate cancer for each male enrolled in the health benefit plan who:

(1)is at least 50 years of age; or

(2)is at least 40 years of age and:

(A)has a family history of prostate cancer; or

(B)exhibits another cancer risk factor.

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 1575.159. COVERAGE FOR PROSTATE-SPECIFIC ANTIGEN TEST. A health benefit plan offered under the group program, other than a Medicare Advantage plan or a Medicare prescription drug plan, must provide coverage for a medically accepted prostate-specific antigen test used for the detection of prostate cancer for each male enrolled in the health benefit plan who:
(1) is at least 50 years of age; or
(2) is at least 40 years of age and:
(A) has a family history of prostate cancer; or
(B) exhibits another cancer risk factor.

Legislative History

Added by Acts 2001, 77th Leg., ch. 1419, Sec. 3, eff. June 1, 2003. Amended by: Acts 2017, 85th Leg., R.S., Ch. 712 (H.B. 3976 ), Sec. 13, eff. September 1, 2017.